Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (917-11-31)
Received: 1 March 2023
Accepted: 10 August 2023
First Online: 30 August 2023
: The study was performed in accordance with the declaration of Helsinki Ethical Principles and Good Clinical Practices and was approved by the local and national ethics committees.
: Not applicable.
: IdB reports independent support from the Dutch heart foundation. GMT reports consultancy support from Novartis, Allergan/Abbvie, Lilly, Teva, and Lundbeck and independent support from Dutch Organization for Scientific Research, the Dutch Heart & Brain Foundations, IRRF and Dioraphte. The other authors report no relevant conflicts of interest.